 |
|
Effects of progesterone on Alzheimer's disease
November 28, 2007Progesterone inhibits some of estrogen's beneficial effects say gerontologists at USC and UC Irvine
The first study on progesterone and Alzheimer's disease has found no clear preventive benefit for the widely prescribed hormone in an animal model.
Progesterone is given with estrogen in hormone replacement therapy. Previous studies have suggested that estrogen offers women some protection against Alzheimer's disease.
The study's authors, led by gerontologist Christian Pike of the University of Southern California, asked if the same could be true of progesterone.
In a study highlighted in this week's issue of the Journal of Neuroscience, Pike's group reports that progesterone has only limited benefit for mice with Alzheimer's symptoms when taken alone.
When taken with estrogen, progesterone actually inhibits some of the other hormone's beneficial effects, the study found.
The problem is not necessarily progesterone itself, Pike said. It could be the constant daily dosage, which fails to replicate the pre-menopausal body's natural cycles of hormone production.
"This is probably not the best way to be delivering progesterone," Pike said. "Giving a constant dose of progesterone appears to antagonize a lot of the beneficial effects of estrogen."
Pike's group tested progesterone on female mice whose hormone production had been blocked to simulate menopause. The mice, which were genetically predisposed to develop an Alzheimer's-like disease, showed symptoms within months.
Treatment with estrogen reversed the symptoms, Pike's group reported. Treatment with progesterone did not.
When the two hormones were given together, progesterone appeared to hinder estrogen's main beneficial function: preventing the buildup of beta amyloid protein, the key risk factor in Alzheimer's.
"Estrogen no longer decreases the amount of beta amyloid" when progesterone is present, Pike said.
Progesterone's effects were not all bad, Pike added. The hormone appeared to inhibit tau hyperphosphorylation, another chemical process implicated in Alzheimer's.
Progesterone also is known to counteract the increased risk of endometrial cancer from estrogen therapy, which is one reason most women receive both hormones.
Pike said his group's study should provide guidance for the design of human trials studying hormone therapy and Alzheimer's. He added that future studies might need to focus both on the dosage and the formulation of progestins -- the synthetic versions of progesterone given to humans -- as well on the starting age for hormone therapy.
Prior to the study, "we really had no idea what the progestins were doing," Pike said.
The study was funded by the National Institute on Aging under a large grant to USC's Roberta Brinton, (Progesterone in Brain Aging and Alzheimer's Disease), who is leading a university-wide effort to study the effects of hormone therapy on women's health.
Doctors prescribe hormone therapy to counter some of the harmful consequences of menopause, such as losses in bone density. But other large studies have shown that hormone therapy also increases the risk of breast cancer.
"Our study mirrors to some extent recent clinical observations in women that hormone therapy appears to have both beneficial and deleterious effects," Pike said.
University of Southern California
The study's authors, led by gerontologist Christian Pike of the University of Southern California, asked if the same could be true of progesterone.
In a study highlighted in this week's issue of the Journal of Neuroscience, Pike's group reports that progesterone has only limited benefit for mice with Alzheimer's symptoms when taken alone.
When taken with estrogen, progesterone actually inhibits some of the other hormone's beneficial effects, the study found.
The problem is not necessarily progesterone itself, Pike said. It could be the constant daily dosage, which fails to replicate the pre-menopausal body's natural cycles of hormone production.
"This is probably not the best way to be delivering progesterone," Pike said. "Giving a constant dose of progesterone appears to antagonize a lot of the beneficial effects of estrogen."
Pike's group tested progesterone on female mice whose hormone production had been blocked to simulate menopause. The mice, which were genetically predisposed to develop an Alzheimer's-like disease, showed symptoms within months.
Treatment with estrogen reversed the symptoms, Pike's group reported. Treatment with progesterone did not.
When the two hormones were given together, progesterone appeared to hinder estrogen's main beneficial function: preventing the buildup of beta amyloid protein, the key risk factor in Alzheimer's.
"Estrogen no longer decreases the amount of beta amyloid" when progesterone is present, Pike said.
Progesterone's effects were not all bad, Pike added. The hormone appeared to inhibit tau hyperphosphorylation, another chemical process implicated in Alzheimer's.
Progesterone also is known to counteract the increased risk of endometrial cancer from estrogen therapy, which is one reason most women receive both hormones.
Pike said his group's study should provide guidance for the design of human trials studying hormone therapy and Alzheimer's. He added that future studies might need to focus both on the dosage and the formulation of progestins -- the synthetic versions of progesterone given to humans -- as well on the starting age for hormone therapy.
Prior to the study, "we really had no idea what the progestins were doing," Pike said.
The study was funded by the National Institute on Aging under a large grant to USC's Roberta Brinton, (Progesterone in Brain Aging and Alzheimer's Disease), who is leading a university-wide effort to study the effects of hormone therapy on women's health.
Doctors prescribe hormone therapy to counter some of the harmful consequences of menopause, such as losses in bone density. But other large studies have shown that hormone therapy also increases the risk of breast cancer.
"Our study mirrors to some extent recent clinical observations in women that hormone therapy appears to have both beneficial and deleterious effects," Pike said.
University of Southern California
Progesterone News and Current Progesterone Events RSSUNC trial: oral contraceptives may ease suffering of women with severe PMS
A new clinical trial at the University of North Carolina at Chapel Hill using a popular low-dose contraceptive could uncover a more effective treatment for the 5 to 10 percent of women who suffer from premenstrual dysphoric disorder (PMDD).
How advanced prostate cancer becomes resistant to androgen-deprivation therapy
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy.
Quest for better treatment for effects of menopause
During menopause, lack of oestrogens increases the risk of suffering cardiovascular diseases. For her doctoral thesis, University of the Basque Country researcher, Ainhoa Ruiz del Agua, studied the effects of substitute treatments and the genetic factors influencing the response to these therapies.
Global menopause summit concludes HRT is safe for healthy women entering menopause
HRT in the early postmenopausal period is safe, and healthy women going through the first few years of the menopause who need HRT to relieve symptoms should have no fears about its use.
Molecular 'clock' could predict risk for developing breast cancer
A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a woman's risk for developing breast cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found.
Treatment advances for fibroids, menopause
Women with fibroids and endometriosis facing the possibility of hysterectomy may now choose less invasive treatment options to preserve fertility, according to Yale professor Aydin Arici, M.D., who will direct a scientific session exploring these alternatives at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting May 3-7 in New Orleans, Louisiana.
Osteoporosis drug Fosamax linked to heart problem
omen who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to research from Group Health and the University of Washington published in the April 28 Archives of Internal Medicine.
A diagnosis of triple-negative breast cancer doesn't always mean cancer spread
Triple-negative breast cancers are a heterogeneous group and may not always be associated with lymph node spread, a new study shows.
Chemotherapy-induced anemia increases risk of local breast cancer recurrence
Patients with breast cancer who developed anemia during chemotherapy had nearly three times the risk of local recurrence as those who did not, according to a study published in the April 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.
Breast cancer subtypes linked to survival from secondary brain tumors
Screening breast cancers for three receptors could help doctors predict the likely survival of patients with brain metastases.
More Progesterone News Articles
 | What Your Doctor May Not Tell You About(TM): Premenopause: Balance Your Hormones and Your Life from Thirty to Fifty (What Your Doctor May Not Tell You About...) by John R. Lee, Jesse Hanley, Virginia Hopkins |
 | What Your Doctor May Not Tell You About Premenopause: Balance Your Hormones and Your Life From Thirty to Fifty by John Lee, Jesse Hanley, Virginia Hopkins Are you a woman between 35 and 50 experiencing PMS, migraine headaches, sudden weight gain, fatigue, irritability, tender or lumpy breasts, memory loss, fibroids, or cold hands and feet? If so, you may be experiencing symptoms of premenopause. Even if you're a decade or more away from menopause, your hormones may already be out of balance, usually caused by an excess of estrogen and a deficiency... |
 | Natural Hormone Replacement For Women Over 45 by John Morgenthaler, Jonathan V. Wright A book showing that natural hormone replacement offers a safe and effective alternative for the treatment of... |
 | What Your Doctor May Not Tell You About Menopause: The Breakthrough Book on Natural Progesterone by John R. Lee, Virginia Hopkins Women considering hormone replacement therapy (HRT) for menopause symptoms and health benefits should read this controversial, provocative book first. "Advertising and research dollars are spent trying to convince women that estrogen will cure everything from heart disease to Alzheimer's," writes John R. Lee, M.D., "but there is scant evidence for any of these claims and reams of evidence that... |
 | Natural Progesterone Cream by C. Norman Shealy Used to treat PMS, migraines, osteoporosis, and... |
 | The Estrogen Alternative: A Guide to Natural Hormonal Balance by Raquel Martin, Judi Gerstung With almost 100,000 copies sold in earlier editions, this revised edition provides the most up-to-date information on natural alternatives to synthetic hormone replacement therapyA must-read for any woman taking synthetic hormones for infertility, birthcontrol, PMS, or menopause• Includes the latest research on using natural progesterone to combat osteoporosis, endometriosis, heart... |
 | What Your Doctor May Not Tell You About Menopause: The Breakthrough Book on Natural Hormone Balance by John R. Lee, Virginia Hopkins The classic bestseller that has helped nearly a million women discover the answer to menopause is now revised and updated. Hot flashes, night sweats, weight gain, low sex drive, hair loss, fibroids, and osteoporosis-most women will experience these or other hormone- related problems at some point as they age. In clear, easy-to-understand language, an internationally recognized expert explains the... |
 | Screaming to Be Heard: Hormonal Connections Women Suspect and Doctors Ignore by Elizabeth Lee Vliet A physician describes how women should and can make their doctors take seriously their physical and emotional problems which are often... |
 | The Estrogen Alternative: Natural Hormone Therapy with Botanical Progesterone by Raquel Martin "Any woman who is considering synthetic hormone therapy or wishes to get off it owes herself the reading of this densely informative book. The simplicity and safety of the solution is almost shocking." (World Health News ... |
| Natural Progesterone: The Multiple Roles of a Remarkable Hormone by John R. Lee |
| © 2008 BrightSurf.com |